Gotteland J P, Loubat C, Planty B, Junquéro D, Delhon A, Halazy S
Medicinal Chemistry Division, Centre de Recherche Pierre Fabre, Castres, France.
Bioorg Med Chem Lett. 1998 Jun 2;8(11):1337-42. doi: 10.1016/s0960-894x(98)00213-3.
Sulfonamide derivatives of ene-yne benzylamine 1 have been prepared and identified as a new class of potent SE inhibitors having demonstrated activity in HepG2 cells as cholesterol biosynthesis inhibitors.
烯炔苄胺1的磺胺衍生物已被制备出来,并被鉴定为一类新型的强效SE抑制剂,已在HepG2细胞中作为胆固醇生物合成抑制剂表现出活性。